Hello and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution that ...

Also, CFO Greg Zante sold 50,309 shares of the company’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $42.75, for a total transaction of $2,150,709.75.

Analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Viking Therapeutics in a research note issued to ...

Welcome to the Viking Therapeutics Fourth Quarter and Full ... Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution ...

Please go ahead, Stephanie. Hello and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd ...